At a glance
- Originator sigma-tau SpA
- Class Antiplatelets
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Septic shock
Most Recent Events
- 20 Jul 1998 No-Development-Reported for Septic shock in Italy (Parenteral)
- 23 Jun 1995 New profile
- 23 Jun 1995 Preclinical development for Septic shock in Italy (Parenteral)